Mutares Juggles Relobus Exit and SABIC Megadeal as Stock Lags Behind Operational Momentum

Munich-based holding company Mutares is running a two-speed narrative. On one side, operational milestones are stacking up — a completed exit in Poland, a record acquisition on the horizon, and a pipeline of further divestitures that management calls the fullest in the firm’s history. On the other, its shares have been drifting lower. The stock closed Tuesday at €26.25, down 12.21% since the start of the year and 20.33% lower on a twelve-month view. Investors are still waiting for the exit story to translate into tangible shareholder returns.

That story gained a concrete chapter on 12 May 2026, when Mutares wrapped up the sale of Relobus Transport Polska. The Polish bus operator, acquired in 2023, was sold to a fund managed by Infracapital, the infrastructure investment arm of M&G. During its stint in the portfolio, Relobus was restructured operationally and financially — tighter bidding discipline, better cost control, and stabilised day-to-day operations. The improvements showed commercially: the company secured two new ten-year public transport contracts in Warsaw, involving 108 buses, and launched a new contract in Gdansk. For Mutares, the deal is a visible proof point that it can buy businesses in early transformation phases and later realise value through a sale.

At the same time, the group is gearing up for the largest acquisition in its history. Mutares is taking over SABIC’s Engineering Thermoplastics division, a deal with around €2 billion in revenue. Closing is expected at the end of June. The move will create an entirely new specialty chemicals segment and beef up Mutares’s presence in the Americas.

The first quarter offered a taste of the underlying momentum. Group revenue rose 10% year on year to just under €1.68 billion, while adjusted operating profit swung firmly into positive territory at €11.1 million. Those numbers support the full-year guidance reiterated by the board: consolidated revenue between €7.9 billion and €9.1 billion, and a holding net profit of €165 million to €200 million. The longer-term ambition remains a compound annual growth rate of at least 25% for both revenue and net profit through 2030.

Should investors sell immediately? Or is it worth buying Mutares?

Debt reduction is running in parallel. At the end of 2025, Mutares had bonds outstanding worth €385 million. By the end of 2026, that figure should fall to between €250 million and €300 million. Starting this quarter, the company plans to repurchase at least €25 million of its own 2023/2027 notes, with a similar minimum buyback each subsequent quarter.

The US expansion is gathering pace too. Mutares is scouting a second office location to complement its existing Chicago base and is working through a transaction pipeline with a combined sales volume of €4.8 billion across roughly 15 potential targets.

Beyond Relobus, the exit pipeline is active. Magirus, the firefighting and defence portfolio company, started the year with a record order intake and has a backlog well north of €800 million. Mutares is exploring strategic options for value realisation — an initial public offering or a sale are both on the table. Magirus’s growing role in the defence sector, which promises higher margins, could support a rich valuation. Separately, another portfolio company is already in an advanced sale process, with management flagging proceeds in the three-digit million range. Such an exit would feed straight into earnings, liquidity and the debt-reduction plan.

Mutares at a turning point? This analysis reveals what investors need to know now.

Shareholders have the annual general meeting on 3 July to look forward to. The board and supervisory board are proposing a base dividend of €2.00 per share for the 2025 financial year. If the expected high-value divestitures materialise in the coming months, a performance dividend could be added on top.

The blueprint is now clear: Relobus provides a realised exit, Magirus and other candidates stand ready to deliver the next earnings boost, and the debt reduction timetable is laid out in quarterly buyback chunks. For the stock to catch up with the operational story, the market will need to see that proven sale pipeline convert into cash — and soon.

Ad

Mutares Stock: New Analysis - 13 May

Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Mutares analysis...

en | DE000A2NB650 | MUTARES | boerse | 69318486 |